Loading clinical trials...
Loading clinical trials...
The purpose of the study is to determine if visual function is improved with implantation of a low-cylinder toric intraocular lens, relative to a non-toric intraocular lens.
The Clareon(R) T2 IOL and the Clareon (R) non-toric IOL will be randomly implanted in subjects determined to be appropriate for the T2 IOL. Visual acuity, low contrast acuity and contrast sensitivity will be measured 3 months postoperatively.
Age
40 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Ifocus øyeklinikk
Haugesund, Norway
Start Date
August 20, 2022
Primary Completion Date
August 30, 2024
Completion Date
August 30, 2024
Last Updated
December 5, 2024
43
ACTUAL participants
low cylinder toric IOL
DEVICE
non-toric IOL implantation
DEVICE
Lead Sponsor
Ifocus Oyeklinikk
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07317661